Paines & Byrne Limited

3rd Floor, Future House, The Glanty, Egham, Surrey, TW20 9AH, UK
Telephone: +44 (0)1784 419 620
Fax: +44 (0)1784 419 583


Summary of Product Characteristics last updated on the eMC: 13/04/2011
SPC Ketovite Liquid


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Ketovite Liquid.


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Vitamin A as palmitate (1.7 x 106 units/g)

HSE

2500

units

Vitamin D2 (ergocalciferol)

BP

400

units

Cyanocobalamin

BP

12.5

microgram

Choline chloride

HSE

150.0

mg


Go to top of the page
3. PHARMACEUTICAL FORM

Oral emulsion.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

As a sugar-free therapeutic supplement for the prevention of vitamin deficiency in conditions such as galactosaemia, disaccharide intolerance, phenylketonuria and other disorders of carbohydrate or amino acid metabolism, as well as in patients who are on restricted, specialised or synthetic diets.

In order to achieve complete vitamin supplementation Ketovite Liquid should be used in conjunction with Ketovite Tablets.


Go to top of the page
4.2 Posology and method of administration

For adults, children and the elderly: 5 ml daily, by oral administration.


Go to top of the page
4.3 Contraindications

Hypersensitivity to the product. Hypercalcaemia.


Go to top of the page
4.4 Special warnings and precautions for use

The recommended dose should not be exceeded without medical advice. No other vitamin supplement containing Vitamins A and D should be taken with Ketovite Liquid except under medical supervision. The methyl parahydroxybenzoate (E218) in Ketovite Liquid may cause allergic reactions which can be delayed. Warning: do not exceed the stated dose.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

Absorption of some vitamins in this preparation may be reduced in conditions of fat malabsorption or with the concurrent use of neomycin, colestyramine, liquid paraffin, aminoglycosides, aminosalicylic acid, anticonvulsants, biguanides, chloramphenicol, cimetidine, colchicine, potassium salts and methyl-dopa. Serum B12 concentrations may be decreased by concurrent administration of oral contraceptives.


Go to top of the page
4.6 Pregnancy and lactation

Caution should be used in pregnancy as excessive doses of Vitamin A may be teratogenic, especially when taken in the first trimester.

Large doses of Vitamin D in lactating mothers may cause hypercalcaemia in infants.


Go to top of the page
4.7 Effects on ability to drive and use machines

None known.


Go to top of the page
4.8 Undesirable effects

None, in the absence of overdosage.


Go to top of the page
4.9 Overdose

Symptoms of overdosage may include anorexia, nausea, vomiting, rough dry skin, polyuria, thirst, loss of hair, painful bones and joints as well as raised plasma and urine calcium and phosphate concentration.

No emergency procedure or antidote is applicable and symptoms are rapidly reduced upon withdrawal of the preparation.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

The product is a multivitamin supplemental product.


Go to top of the page
5.2 Pharmacokinetic properties

The pharmacokinetics of the active substances would not differ from that of the same substance when derived naturally from oral foodstuffs.


Go to top of the page
5.3 Preclinical safety data

No relevant pre-clinical data has been generated.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Methyl cellulose (methocel E4M)

HSE

Saccharin

BP

Methyl parahydroxybenzoate

BP

Polysorbate 80

BP

Ascorbic acid

BP

DL α tocopherol

HSE

Terpeneless orange oil

BP

Ammonia solution 0.88m

HSE

Deionised water

HSE


Go to top of the page
6.2 Incompatibilities

None known.


Go to top of the page
6.3 Shelf life

24 months.


Go to top of the page
6.4 Special precautions for storage

Store at 2-8°C.


Go to top of the page
6.5 Nature and contents of container

Amber glass bottle with plastic screw cap. Park sizes 100, 150 and 140.


Go to top of the page
6.6 Special precautions for disposal and other handling

Not applicable.


Go to top of the page
Administrative Data

Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Paines and Byrne Limited

3rd Floor

Future House

The Glanty

Egham

Surrey

TW20 9AH

United Kingdom


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL0051/5080R


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

First authorisation granted 30 January 1990

Renewal granted 9 September 2005


Go to top of the page
10. DATE OF REVISION OF THE TEXT

13th December 2010


Go to top of the page
11. LEGAL CATEGORY

P



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/1407/SPC/


Active Ingredients/Generics

 
   multivitamins